Tirzepatide (Mounjaro, Persovance)
Tirzepatide
Eli Lilly (S.A.) (Pty) Ltd
Registration
- Applicant
- Eli Lilly (S.A.) (Pty) Ltd
- Registrations
- 12
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Mounjaro 2,5 MG EACH 0,5 ml SOLUTION CONTAINS TIRZEPATIDE 2,5 mg | 2,5 mg | 57082157/21.13/0821 | Registered | Not determined | None |
| Mounjaro 5 MG EACH 0,5 ml SOLUTION CONTAINS TIRZEPATIDE 5,0 mg | 5 mg | 57082257/21.13/0822 | Registered | Not determined | None |
| Mounjaro 7,5 MG EACH 0,5 ml SOLUTION CONTAINS TIRZEPATIDE 7,5 mg | 7,5 mg | 57082357/21.13/0823 | Registered | Not determined | None |
| Mounjaro 10 MG EACH 0,5 ml SOLUTION CONTAINS TIRZEPATIDE 10,0 mg | 10 mg | 57082457/21.13/0824 | Registered | Not determined | None |
| Mounjaro 12,5 MG EACH 0,5 ml SOLUTION CONTAINS TIRZEPATIDE 12,5 mg | 12,5 mg | 57082557/21.13/0825 | Registered | Not determined | None |
| Mounjaro 15 MG EACH 0,5 ml SOLUTION CONTAINS TIRZEPATIDE 15,0 mg | 15 mg | 57082657/21.13/0826 | Registered | Not determined | None |
| Persovance 2,5 MG EACH 0,5 ml SOLUTION CONTAINS TIRZEPATIDE 2,5 mg | 2,5 mg | 570827.82157/21.13/0827.821 | Registered | Not determined | None |
| Persovance 5 MG EACH 0,5 ml SOLUTION CONTAINS TIRZEPATIDE 5,0 mg | 5 mg | 570828.82257/21.13/0828.822 | Registered | Not determined | None |
| Persovance 7,5 MG EACH 0,5 ml SOLUTION CONTAINS TIRZEPATIDE 7,5 mg | 7,5 mg | 570829.82357/21.13/0829.823 | Registered | Not determined | None |
| Persovance 10 MG EACH 0,5 ml SOLUTION CONTAINS TIRZEPATIDE 10,0 mg | 10 mg | 570830.82457/21.13/0830.824 | Registered | Not determined | None |
| Persovance 12,5 MG EACH 0,5 ml SOLUTION CONTAINS TIRZEPATIDE 12,5 mg | 12,5 mg | 570831.82557/21.13/0831.825 | Registered | Not determined | None |
| Persovance 15 MG EACH 0,5 ml SOLUTION CONTAINS TIRZEPATIDE 15,0 mg | 15 mg | 570832.82657/21.13/0823.826 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
No structure available
This product's active ingredient could not be matched to a single known compound.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.